Preliminary research has shown that antibodies produced as a result of infection or vaccines against the coronavirus are sufficient to protect against the new variant of covid BA.2.86, the US Centers for Disease Control and Prevention (CDC) announced, reports the Voice of America.
This is in disagreement with the CDC's earlier estimates from August 2022 that, compared to the previous ones, the new variant of covid could cause infection to a greater extent from citizens who were sick or were vaccinated.
The Food and Drug Administration is expected to approve improved vaccines in the coming days that should provide protection against the KSBB.1.5 subvariant of Omicron.
Preliminary data indicate that the performance of the new vaccines may be encouraging, the CDC said.
The Public Health Agency announced that the new strain of covid 19 did not affect the increase in new cases of covid 19 and hospitalizations in the United States of America (USA).
However, she linked that trend to other viruses circulating in the country.
Since last Friday, the covid strain BA.2.86 has been reported in nine US states. In addition, it has been established in Japan, Great Britain and Canada.
Bonus video:
